Incidentally Detected Malignancies in Lung Transplant Explants

Active malignancy diagnosed within 5 years is an absolute contraindication for lung transplantation. In this study, we evaluated the rate of incidental malignancies detected in explanted lungs at our institution and assessed the posttransplant survival in patients with nonsmall cell lung cancer (NSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Amratia, Dhruv A., Hunt, William R., Neujahr, David, Veeraraghavan, Srihari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Lung Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831122/
https://www.ncbi.nlm.nih.gov/pubmed/31773056
http://dx.doi.org/10.1097/TXD.0000000000000947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831122/
https://www.ncbi.nlm.nih.gov/pubmed/31773056
http://dx.doi.org/10.1097/TXD.0000000000000947

Ejemplares similares